This opportunity is no longer accepting applications.
grant PAR-23-168

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

This grant aims to support research focused on discovering and developing new small molecules that could help study treatments for psychiatric disorders. Additionally, it seeks to enhance understanding of the biology of diseases and processes that are still being explored as potential drug targets.

The objective of this funding opportunity announcement (FOA) is to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to psychiatric disorders; and 2) to generate new insight into the biology of relevant dis…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health
Program: SBIR

Dates

Open for Submission: April 17, 2023
Application Window Closes: May 7, 2026
Opportunity Released: April 17, 2023
Submission Deadline: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.